- Condition: Ankylosing Spondylitis
Interventions: Other: aerobic training; Other: Stretching exercises
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified April 2012 - Condition: Ankylosing Spondyloarthritis
Interventions: Drug: Apremilast tablet 20 mg; Drug: Apremilast tablet 30 mg BID; Drug: Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified May 2012 - Condition: Inflammatory Joint Diseases
Intervention:
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University Hospital of North Norway; St. Olavs Hospital; Lillehammer Hospital for Rheumatic Diseases; Vestre Viken HF Drammen Hospital
Recruiting - verified April 2012 - Conditions: Osteoarthritis (OA); Rheumatoid Arthritis (RA); Ankylosing Spondylitis (AS)
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified April 2012 - Condition: Spondylitis, Ankylosing
Intervention:
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis; Other Arthritic Conditions (e.g., Psoriatic Arthritis)
Intervention: Behavioral: painACTION: Arthritis
Sponsors: Inflexxion, Inc.; Inflexxion, Inc.
Recruiting - verified October 2011 - Condition: Ankylosing Spondylitis
Intervention: Behavioral: Exercise
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University of Oslo
Recruiting - verified October 2011 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Golimumab; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough; Johnson & Johnson
Recruiting - verified April 2012 - Conditions: Cytokine Environment; Kinetics of Bone Cells Differentiation and Activity in Untreated RA and AS Patients.
Intervention:
Sponsors: Instituto de Medicina Molecular; Instituto de Medicina Molecular; Merck
Not yet recruiting - verified December 2011 - Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
Sponsors: Shandong University; Shandong University
Recruiting - verified April 2011 - Conditions: Arthritis; Spondylitis, Ankylosing
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: Abbott; Abbott; JSS Medical Research Inc.; CATO Research Canada
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention: Drug: Enbrel
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis
Intervention: Other: Exercise
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified May 2011 - Condition: Ankylosing Spondylitis
Intervention: Drug: Ustekinumab
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified October 2011 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Intervention: Drug: Simponi®
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis
Interventions: Device: Augment(tm) Injectable Bone Graft; Procedure: Autologous bone graft
Sponsors: BioMimetic Therapeutics; BioMimetic Therapeutics
Recruiting - verified July 2011 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Spondylitis, Ankylosing
Interventions: Biological: etanercept; Drug: Background NSAID; Other: PLACEBO; Drug: Background NSAID
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis(AS)
Interventions: Drug: Simponi; Other: 0.9ml sodium chloride
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified February 2012 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to etoricoxib 60 mg; Drug: Part I - Placebo to etoricoxib 90 mg; Drug: Part I - Placebo to naproxen 500 mg; Drug: Part II- etoricoxib 60 mg; Drug: Part II- etoricoxib 90 mg; Drug: Part II- naproxen 1000 mg; Drug: Part II - Placebo to etoricoxib 60 mg; Drug: Part II - Placebo to etoricoxib 90 mg; Drug: Part II - Placebo to naproxen 500 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Spondyloarthritis; Intestinal Inflammation
Intervention: Drug: Adalimumab
Sponsors: Regionshospitalet Silkeborg; Regionshospitalet Silkeborg; Abbott; European Capsule Endoscopy Group; The Central Denmark Region
Recruiting - verified July 2011 - Condition: Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 NSAIDs.
Intervention: Drug: Etoricoxib
Sponsors: Spanish Foundation of Rheumatology; Spanish Foundation of Rheumatology
Recruiting - verified October 2010 - Condition: Ankylosing Spondylitis
Intervention: Drug: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention: Drug: anti-TNF therapy (etanercept or adalimumab)
Sponsors: Imperial College London; Imperial College London
Recruiting - verified September 2011 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Endothelial Dysfunction; Inflammatory Disease Activity
Intervention:
Sponsors: Revmatismesykehuset AS; Revmatismesykehuset AS; Abbott
Recruiting - verified May 2009 - Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Conditions: Crohn's Disease; Ankylosing Spondylitis
Intervention: Biological: Infliximab
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified August 2011 - Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Spondylitis, Ankylosing
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012
 |
Join Clinical Trials for Ankylosing spondylitis, and other forms of Arthritis |
